Company Performance: VOYT.US stock price is heavily influenced by Voyager Therapeutics' financial health, including revenue, profitability, and cash flow.

Clinical Trial Results: Positive data from Voyager's gene therapy clinical trials often drive up stock price, while negative or inconclusive results can cause it to fall.

Regulatory Approvals: FDA decisions regarding Voyager's therapies significantly impact investor confidence and, consequently, the stock price.

Market Conditions: Overall market sentiment, particularly in the biotechnology sector, affects VOYT.US. A bullish market tends to lift most stocks, while a bearish one can pull them down.

Competition: The presence and progress of competing gene therapies from other companies can affect investor perception of Voyager's potential market share and thus its stock price.

Partnerships and Collaborations: Announcements of strategic partnerships or collaborations with larger pharmaceutical companies are generally viewed favorably, boosting VOYT.US stock.

Economic Factors: Broader economic conditions, such as interest rates and inflation, can also influence investor decisions and stock valuations.

News and Events: General news related to the company and related events.